MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities
- 12 January 2007
- journal article
- lab investigation
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 83 (2) , 173-179
- https://doi.org/10.1007/s11060-006-9320-0
Abstract
MGMT promoter methylation, which has been correlated with the response to alkylating agents, was investigated in a retrospective series of 219 glioblastomas (GBMs) treated with various modalities. MGMT methylation had no impact on survival for the whole group, but showed a significant advantage (17.1 months vs. 13.1) for patients treated with RT+ adjuvant chemotherapy (relative risk of death (RR) = 0.53; P = 0.041), particularly when patients received CT during the course of RT (MS = 19.9 months vs. 12.5 months; RR = 0.227, P = 0.001). This suggests that the prognostic impact of MGMT methylation is dependent on therapeutic modalities and schedules. MGMT methylation was not correlated with the main molecular alterations, such as 10q loss and p53 expression.Keywords
This publication has 27 references indexed in Scilit:
- Prognostic impact of molecular markers in a series of 220 primary glioblastomasCancer, 2006
- Tumor Progression Through Epigenetic Gene Silencing of O6−Methylguanine-DNA Methyltransferase in Human Biliary Tract CancersAnnals of Surgical Oncology, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Inverse Correlation Between the Expression of O6-Methylguanine-DNA Methyl Transferase (MGMT) and p53 in Breast CancerJapanese Journal of Clinical Oncology, 2005
- O6-methylguanine-DNA methyltransferase methylation andTP53 mutation in malignant astrocytomas and their relationships with clinical courseInternational Journal of Cancer, 2004
- Killing and mutagenic actions of dacarbazine, a chemotherapeutic alkylating agent, on human and mouse cells: effects of Mgmt and Mlh1 mutationsDNA Repair, 2004
- Roles of MGMT and MLH1 proteins in alkylation-induced apoptosis and mutagenesisDNA Repair, 2003
- Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedulesBritish Journal of Cancer, 2003
- p53 is involved in regulation of the DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agentsOncogene, 1998
- Induction of the alkyltransferase (MGMT) gene by DNA damaging agents and the glucocorticoid dexamethasone and comparison with the response of base excision repair genesCarcinogenesis: Integrative Cancer Research, 1996